Skip to main content
SpringerLink
Log in

Synthesis, biological evaluation and biodistribution of the 99mTc–Garenoxacin complex in artificially infected rats

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

The labeling of garenoxacin (GXN) with technetium-99m (99mTc) using different concentrations of GXN, sodium pertechnetate (Na99mTcO4), stannous chloride dihydrate (SnCl2·2H2O) at different pH was investigated and evaluated in terms of in-vitro stability in saline, serum, binding with multi-resistant Staphylococcus aureus (MDRSA) and penicillin-resistant Streptococci (PRSC) and its biodistribution in artificially MDRSA and PRSC infected rats. 99mTc–GXN complex with 97.45 ± 0.18% radiochemical stability was prepared by mixing 3 mg of GXN with 3 mCi of Na99mTcO4 in the presence of 150 μL of SnCl2·2H2O (1 μg/μL in 0.01 N HCl) at a pH 5.6. The radiochemical stability of the complex was evaluated in normal saline up to 240 min of reconstitution. It was observed that the complex showed maximum RCP values after 30 min of the reconstitution and remained more than 90% up to 240 min. The complex showed radiochemical stability in normal saline at 37 °C up to 16 h with a 17.80% de-tagging. The complex showed saturated in-vitro binding with living MDRSA and PRSC as compared to the insignificant binding with heat killed MDRSA and PRSC. Biodistribution behavior of the complex was assessed in artificially infected with living and heat killed MDRSA and PRSC rats. It was observed that the accumulation of the complex in the infected (live MDRSA and PRSC) tissue of the rats was almost five fold than in the inflamed and normal tissue. The high radiochemical stability in normal saline at room temperature, promising in-vitro stability in serum at 37 °C, saturated in-vitro binding with living MDRSA and PRSC, specific biodistribution behavior and high infected (target) to normal (non-target) tissue and low inflamed (non-target) to normal (non-target) tissue ratios we recommend 99mTc–GXN complex for in-vivo localization of infection caused by MDRSA and PRSC effective stains.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Gallagher H, Ramsay SC, Barnes J, Maggs J, Cassidy N, Ketheesan N (2006) Neutrophil labeling with [99mTc]-technetium stannous colloid is complement receptor 3-mediated and increases the neutrophil priming response to lipopolysaccharide. Nucl Med Biol 33:433

    Article  CAS  Google Scholar 

  2. Stumpe KDM, Dazzi H, Schaffner A, Schulthess GK (2000) Infection imaging using whole-body FDG-PET. Eur J Nucl Med 27:822

    Article  CAS  Google Scholar 

  3. Chattopadhyay S, Das SS, Chandra S, De K, Mishra M, Sarkar BR, Sinha S, Ganguly S (2010) Synthesis and evaluation of 99mTc-moxifloxacin, a potential infection specific imaging agent. Appl Radiat Isot 68:314

    Article  CAS  Google Scholar 

  4. Motaleb MA (2007) Preparation of 99mTc–cefoperazone complex, a novel agent for detecting sites of infection. J Radioanal Nucl Chem 272:167

    Article  CAS  Google Scholar 

  5. Motaleb MA (2007) Preparation and biodistribution of 99mTc–lomefloxacin and 99mTc–olfloxacin complex. J Radioanal Nucl Chem 272:95

    Article  CAS  Google Scholar 

  6. Zhang J, Guo H, Zhang S, Lin Y, Wang X (2008) Synthesis and biodistribution of a novel 99mTcN complex of ciprofloxacin dithiocarbamate as a potential agent for infection imaging. Bioorg Med Chem Lett 18:51

    Google Scholar 

  7. Roohi S, Mushtaq A, Jehangir M, Ashfaq MS (2006) Synthesis, quality control and biodistribution of 99mTc-Kanamycin. J Radioanal Nucl Chem 267:561

    Article  CAS  Google Scholar 

  8. Oh SJ, Ryu J, Shin JW, Yoon EJ, Ha H, Cheon JH, Lee HK (2002) Synthesis of 99mTc-ciprofloxacin by different methods and its biodistribution. Appl Radiat Isot 57:193

    Article  CAS  Google Scholar 

  9. EL-Gany EA, EL-Kolaly MT, Amine AM, EL-Sayed AS, Abdel-Gelil F (2005) Synthesis of 99mTc-pefloxacin: a new targeting agent for infectious foci. J Radioanal Nucl Chem 266:131

    Article  Google Scholar 

  10. Motaleb MA (2009) Preparation, quality control and stability of 99mTc–sparafloxacin complex, a novel agent for detecting sites of infection. J Label Compd Radiopharm 52:415

    Article  CAS  Google Scholar 

  11. Xia J, Wang Y, Yu J, Li S, Tang L, Zheng M, Liu X, Li G, Cheng D, Liang S, Yin D (2008) Synthesis, in vitro and in vivo behavior of 188Re(I)–tricarbonyl complexes for the future functionalization of biomolecules. J Radioanal Nucl Chem 275:325

    Article  CAS  Google Scholar 

  12. Zhang J, Wang X, Jin C (2007) Synthesis and biodistribution of the 99mTc(CO)3–DEDT complex as a potential new radiopharmaceutical for brain imaging. J Radioanal Nucl Chem 272:91

    Article  CAS  Google Scholar 

  13. Djokic DD, Jankovic DL, Stamenkovic LL, Pirmettis I (2004) Chemical and biological evaluation of 99mTc (CO)3 and 99mTc complexes of some IDA derivatives. J Radioanal Nucl Chem 260:471

    Article  CAS  Google Scholar 

  14. Xia J, Long S, Yu J, Wang Y, Cao Z (2009) Pyridyl derivatives provide new pathways for labeling protein with fac-[188Re(CO)3(H2O)3]+. J Radioanal Nucl Chem 281:493

    Article  CAS  Google Scholar 

  15. Zhang JB, Wang XB, Jin C (2006) Synthesis of 99mTc(CO)3-NOET via [99mTc(OH2)3(CO)3]+ precursor and comparative biological studies with 99mTcN-NOET. J Radioanal Nucl Chem 269:227

    Article  CAS  Google Scholar 

  16. Qaiser SS, Khan AU, Khan MR (2010) Synthesis, biodistribution and evaluation of 99mTc-sitafloxacin kit: a novel infection imaging agent. J Radioanal Nucl Chem 284:189

    Article  CAS  Google Scholar 

  17. Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis of 99mTc-nitrifuratonin a novel radiotracer for in vivo imaging of Escherichia coli infection. J Radioanal Nucl Chem. doi:10.1007/s10967-010-0697-z

  18. Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis and biodistribution of 99mTc-rifampicin: a novel radiotracer for in vivo infection imaging. Appl Radiat Isot 68:2255

    Article  CAS  Google Scholar 

  19. Shah SQ, Khan AU, Khan MR (2010) 99mTc-novobiocin: a novel radiotracer for infection imaging. Radiochim Acta (in press)

  20. Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis, biodistribution and scintigraphy of the 99mTc–teicoplanin complex in artificially infected animal models. J Label Compd Radiopharm (in press)

  21. Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis and biological evaluation of 99mTcN-sitafloxacin dithiocarbamate as potential radiotracer for Staphylococcus aureus infection. J Radioanal Nucl Chem. doi:10.1007/s10967-010-0833-9

  22. Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis and biodistribution of 99mTcN–garenoxacin dithiocarbamate complex a potential infection imaging agent. J Radioanal Nucl Chem. doi:10.1007/s10967-010-0871-3

  23. Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis and biological evolution of 99mTc(CO)3–sitafloxacin dithiocarbamate complex: a promising Staphylococcus aureus infection radiotracer. J Radioanal Nucl Chem. doi:10.1007/s10967-010-0880-2

  24. Shah SQ, Khan AU, Khan MR (2010) 99mTc(CO)3-garenoxacin dithiocarbamate synthesis and biological evolution in rats infected with multiresistant Staphylococcus aureus and penicillin-resistant Streptococci. J Radioanal Nucl Chem. doi: 10.1007/s10967-010-0892-y

  25. Sader HS, Fritsche TR, Jones RN (2007) In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999–2004). Diagn Microbiol Infect Dis 58:27

    Article  CAS  Google Scholar 

  26. Roblin PM, Reznik T, Hammerschlag MR (2003) In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniae. Int J Antimicrob Agents 21:578

    Article  CAS  Google Scholar 

  27. Welling MM, Paulusma-Annema A, Batler HS, Pauwels EKJ, Nibbering PH (2000) Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 27:292

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine Research Laboratory (NMRL), University of Peshawar, Peshawar, KPK, Pakistan

    Syed Qaiser Shah

  2. Nuclear Medicine, Oncology and Radiotherapy Institute (NORI), Islamabad, Pakistan

    Aakif Ullah Khan

  3. Phytopharmaceutical and Neutraceuticals Research Laboratory (PNRL), University of Peshawar, Peshawar, KPK, Pakistan

    Muhammad Rafiullah Khan

Authors
  1. Syed Qaiser Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aakif Ullah Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Muhammad Rafiullah Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Syed Qaiser Shah.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shah, S.Q., Khan, A.U. & Khan, M.R. Synthesis, biological evaluation and biodistribution of the 99mTc–Garenoxacin complex in artificially infected rats. J Radioanal Nucl Chem 288, 207–213 (2011). https://doi.org/10.1007/s10967-010-0896-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-010-0896-7

Keywords

Search

Navigation